Mother-to-Child HIV Transmission: Risks, Prevention, and Modern Outcomes

Mother-to-child transmission (MTCT) of HIV can occur during pregnancy, labor/delivery, or breastfeeding. Without intervention, transmission rates range from 15% to 45%. With comprehensive prevention, rates drop to below 1% in resource-rich settings and <5% globally.

Transmission Routes & Timing

  • In utero (pregnancy): HIV crosses placenta, especially in third trimester; higher with high maternal viral load.
  • Intrapartum (delivery): Exposure to maternal blood and genital secretions during vaginal birth; accounts for ~50% of transmissions without intervention.
  • Postpartum (breastfeeding): HIV in breast milk; risk ~5–20% if breastfeeding for 18–24 months without ART.

Prevention Strategy (WHO "Four Prongs")

  1. Primary prevention of HIV in women of childbearing age.
  2. Prevent unintended pregnancies in HIV-positive women.
  3. Prevent transmission from mother to infant:
    • Antiretroviral therapy (ART) for mother: Start ASAP, goal undetectable viral load (<50 copies/mL) by delivery.
    • Elective C-section at 38 weeks if viral load >1,000 copies/mL or unknown; not needed if suppressed.
    • Infant prophylaxis: Zidovudine (AZT) ± nevirapine for 2–6 weeks based on maternal viral load and breastfeeding status.
    • Avoid breastfeeding where safe alternatives exist (formula, clean water). If breastfeeding, maternal ART + infant prophylaxis throughout.
  4. Care, treatment, and support for mothers and families living with HIV.

Outcomes

With early diagnosis, sustained ART, and safe delivery/infant feeding practices, MTCT is now a rare event. Ongoing challenges include late presentation, adherence, stigma, and access in low-resource regions.

HIV & AIDS - Related Articles